These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31379459)

  • 1. Preanalytical classical and alternative complement pathway activity loss.
    Vercauteren KOA; Lambrecht S; Delanghe J
    Biochem Med (Zagreb); 2019 Oct; 29(3):030701. PubMed ID: 31379459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between the haemolytic activities of the human complement system and complement components.
    Takada A; Imamura Y; Takada Y
    Clin Exp Immunol; 1979 Feb; 35(2):324-8. PubMed ID: 436337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel assay for serum complement activity: C42 generation assay.
    Kobayashi E; Kitano E; Kitamura H
    Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the 50% haemolytic complement (CH50) activity of serum.
    Costabile M
    J Vis Exp; 2010 Mar; (37):. PubMed ID: 20351687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation?
    van Son WJ; van der Bij W; Tegzess AM; Anema J; van der Giessen M; van der Hem GK; Marrink J; The TH
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):109-21. PubMed ID: 2535976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of complement pathways in xenotransplantation: an in vitro study.
    Walpen AJ; Mohacsi P; Frey C; Roos A; Daha MR; Rieben R
    Transpl Immunol; 2002 May; 9(2-4):271-80. PubMed ID: 12180841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
    Zwirner J; Dobos G; Götze O
    J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of complement activation by counterimmunoelectrophoresis (CIE).
    Arroyave CM; Tan EM
    J Immunol Methods; 1976; 13(2):101-12. PubMed ID: 824368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians.
    Bellavia D; Fradà G; Di Franco P; Feo S; Franceschi C; Sansoni P; Brai M
    J Gerontol A Biol Sci Med Sci; 1999 Apr; 54(4):B150-3. PubMed ID: 10219002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Tool for Complement Research:
    Mutti M; Ramoni K; Nagy G; Nagy E; Szijártó V
    Front Immunol; 2018; 9():2770. PubMed ID: 30564230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury.
    Kotimaa J; van der Pol P; Leijtens S; Klar-Mohammad N; Schilders G; Daha MR; Rutjes H; van Kooten C
    J Immunol Methods; 2014 Oct; 412():14-23. PubMed ID: 24953215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of proteinase activity of complement system by immunoenzyme methods].
    Romanov SV; Kozlov LV; D'iakov VL; Batalova TN; Guzova VA
    Biomed Khim; 2003; 49(6):604-12. PubMed ID: 16119089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.